Financials Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 2026-09-28			5-day change	1st Jan Change
33.88 ^CNY	-4.43%		-5.63%	+92.50%

09-20	Shandong Linuo Pharmaceutical Packaging Co., Ltd.(XSEC:301188) added to S&P Global BMI Index	CI
08-24	Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	888.9	822	947.4	1,081	981.5	1,090	1,238	1,417
Change	-	-7.52%	15.25%	14.09%	-9.19%	11.06%	13.58%	14.46%
EBITDA ¹	199.5	196.4	159.5	199.1	-	240	313	409
Change	-	-1.55%	-18.79%	24.86%	-	-	30.42%	30.67%
EBIT ¹	140.5	127	72.89	72.11	50.62	118	158	224
Change	-	-9.62%	-42.59%	-1.06%	-29.8%	133.1%	33.9%	41.77%
Interest Paid ¹	-2.243	-	-4.801	-	-	-14	-16	-17
Earnings before Tax (EBT) ¹	140.3	126.7	72.81	71.45	49.22	117	158	223
Change	-	-9.66%	-42.55%	-1.86%	-31.11%	137.71%	35.04%	41.14%
Net income ¹	124.8	116.7	65.92	66.07	39.66	103	137	190
Change	-	-6.51%	-43.49%	0.23%	-39.97%	159.7%	33.01%	38.69%
Announcement Date	2/18/22	4/26/23	4/28/24	4/24/25	4/22/26	-	-	-

¹CNY in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	2/18/22	4/26/23	4/28/24	4/24/25	4/22/26	-	-	-

Estimates

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	161.8	113.3	209.1	277.9	250	250	250
Change	-	-29.96%	84.54%	32.9%	-10.04%	0%	0%
Free Cash Flow (FCF) ¹	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
Announcement Date	4/26/23	4/28/24	4/24/25	4/22/26	-	-	-

¹CNY in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	22.44%	23.89%	16.84%	18.42%	-	22.02%	25.28%	28.86%
EBIT Margin (%)	15.8%	15.44%	7.69%	6.67%	5.16%	10.83%	12.76%	15.81%
EBT Margin (%)	15.78%	15.42%	7.69%	6.61%	5.01%	10.73%	12.76%	15.74%
Net margin (%)	14.04%	14.19%	6.96%	6.11%	4.04%	9.45%	11.07%	13.41%
FCF margin (%)	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	-	-	-
Profitability
ROA	-	7.29%	3.48%	2.93%	-	3.9%	4.9%	6.4%
ROE	12.16%	8.38%	4.59%	4.29%	2.52%	6.2%	7.8%	9.9%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	19.68%	11.96%	19.35%	28.32%	22.94%	20.19%	17.64%
CAPEX / EBITDA (%)	-	82.38%	71.05%	105.01%	-	104.17%	79.87%	61.12%
CAPEX / FCF (%)	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	0.2258	0.1996	0.2641	-	-0.0808	-	-	-
Change	-	-11.6%	32.31%	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	5.856	6.158	6.242	6.216	-	-	-	-
Change	-	5.17%	1.36%	-0.43%	-	-	-	-
EPS ¹	0.7	0.5	0.3	0.29	0.17	0.39	0.51	0.71
Change	-	-28.57%	-40%	-3.33%	-41.38%	129.41%	30.77%	39.22%
Nbr of stocks (in thousands)	232,410	232,410	232,410	228,926	232,645	259,454	259,454	259,454
Announcement Date	2/18/22	4/26/23	4/28/24	4/24/25	4/22/26	-	-	-